4.7 Article

Antibiotic tolerance, persistence, and resistance of the evolved minimal cell, Mycoplasma mycoides JCVI-Syn3B

期刊

ISCIENCE
卷 24, 期 5, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.isci.2021.102391

关键词

-

资金

  1. National Science Foundation [1922542, 1849206]
  2. USDA National Institute of Food and Agriculture Hatch project [SD00H653-18, 1015687]
  3. Direct For Biological Sciences
  4. Div Of Molecular and Cellular Bioscience [1922542] Funding Source: National Science Foundation

向作者/读者索取更多资源

Antibiotic persistence plays a significant role in the evolution of antibiotic resistance and relapsing infections. The minimal cell Mycoplasma mycoides JCVI-Syn3B evolves antibiotic resistance quickly to different types of antibiotics and exhibits tolerance and persistence against multiple antibiotics.
Antibiotic resistance is a growing problem, but bacteria can evade antibiotic treatment via tolerance and persistence. Antibiotic persisters are a small subpopulation of bacteria that tolerate antibiotics due to a physiologically dormant state. Hence, persistence is considered a major contributor to the evolution of antibiotic-resistant and relapsing infections. Here, we used the synthetically developed minimal cell Mycoplasma mycoides JCVI-Syn3B to examine essential mechanisms of antibiotic survival. The minimal cell contains only 473 genes, and most genes are essential. Its reduced complexity helps to reveal hidden phenomenon and fundamental biological principles can be explored because of less redundancy and feedback between systems compared to natural cells. We found that Syn3B evolves antibiotic resistance to different types of antibiotics expeditiously. The minimal cell also tolerates and persists against multiple antibiotics. It contains a few already identified persister-related genes, although lacking many systems previously linked to persistence (e.g. toxin-antitoxin systems, ribosome hibernation genes).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据